The current meta-analysis revealed a significant effect of probiotics and synbiotics on reducing the level of the CRP marker in patients with prediabetes and T2DM (WMD: −0.46; 95% CI: −0.76, −0.15). This evidence concerns the gene CRP and prediabetes syndrome.